Alcon to present new TRYPTYR dry eye clinical research at Academy 2026

Alcon says it will present findings on acoltremon (TRYPTYR) 0.003% from Sept. 30 to Oct. 3 in Anaheim, focusing on patient-reported quality of life, daily functioning, symptoms and treatment satisfaction.